Vikrant Shekhawat : Jun 05, 2021, 06:58 AM
New Delhi. According to the Brake Through Study of All India Institute of Medical Sciences (AIIMS), no one has died due to the infection of any person who vaccinated vaccine. If the person taking a vaccine becomes infected, then it is called Brake Thru Infection. AIIMS has done this study between April to May. Meanwhile, the wave of Corona in the country was at its peak and about 4 lakh people were getting infected every day. According to AIIMS Study, the people who had taken both the Kovid vaccine, the infection of the Karaana was done, but Kovid did not die.It has been said in the study that any person who is taking vaccine has not died due to infected in Corona. AIIMS has studied through genome sequencing of 63 cases of brake thru infection. Of these, 36 patients had both doses of vaccine, while 27 had taken at least one dose. The 10 patients involved in this study took the Covishered vaccine, while 53 had a covecy. None of these patients were not killed due to infectation.According to the study, most cases of infection in Delhi are alike and in the case of infection, Koreona's B.1.617.2 and B.1.1.17 strain is being seen in most cases. It has been said in the report that the cases of brake thru infection were earlier, but in most cases the transition was light. In any case the person's health was not serious nor did anyone died.The average age of people involved in the study was 37 years old, and the youngest person was 21 years old, while the oldest person was 92 years old. Among them 41 men and 22 women were included. Any patient did not have any serious illness already.However, there is still a lack of awareness in people about the vaccine. A few days ago, the news came that in a village in Barabanki district of Uttar Pradesh, when the health workers went to the vaccine of Corona, some people jumped into the river from the fear of the vaccine. Need to understand that there is no danger of any kind of Corona virus vaccine and the vaccine has been declared secure in the clinical trial. Therefore, on the basis of priority, the vaccine needs to be rescued from Corona.